General considerations in inhalation therapy.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002320:Cardiovascular Physiological Phenomena; D002490:Central Nervous System / Q000502:physiology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D006801:Humans; D008991:Monitoring, Physiologic; D010102:Oxygen Inhalation Therapy; D011175:Positive-Pressure Respiration; D012143:Respiratory Physiological Phenomena; D012138:Respiratory Therapy; D012140:Respiratory Tract Diseases / Q000209:etiology* / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D000697:Central Nervous System Stimulants